The financial statements of dsm-firmenich include both the Consolidated Financial Statements and the Parent Company Financial Statements.
The Group’s parent company, DSM-Firmenich AG, is domiciled in Kaiseraugst (Switzerland) and listed on the Euronext Amsterdam stock exchange. The following Consolidated Financial Statements comprise DSM-Firmenich AG and its subsidiaries (the ‘Group’) and are prepared in accordance with IFRS. The Group is a leading supplier in nutrition, health, and beauty. See also Note 1 General Information.
A list of the Group’s main subsidiaries can be found in Note 3 Investments to the Parent Company Financial Statements. The financial year 2025 covers the period from January 1, 2025 to December 31, 2025. The Board of Directors of DSM-Firmenich AG approved these statements for issue on February 19, 2026 and they are subject to the approval of the Annual General Meeting on May 7, 2026.
The accompanying notes are an integral part of these Consolidated Financial Statements. See Note 2 Alternative performance measures for the reconciliation to Adjusted EBITDA of €1,772 million (2024: €1,751 million) and other non-IFRS performance measures.